-
CORV Is Back, SENS' Eversense Gets Aetna Coverage, ACRX Nears FDA Decision Day
24 Oct 2018 00:49 GMT
… in the pharma/biotech sector.
1. Correvio Pharma … BRINAVESS, formerly known as Kynapid, in the U.S. … FSD Pharma, and the medical and pharmaceutical brands by Therapix Biosciences. … Limited. The drug, (TDF), is indicated for the treatment of hepatitis …
-
FDA Greelinghts PGNX' Azedra, MYND Delighted, CORV Looks Ahead With Hope
31 Jul 2018 00:49 GMT
… gainers in the pharma/biotech sector.
1. MYnd Analytics Inc … for BRINAVESS, formerly known as Kynapid, in the U.S. … . (PAVM)
PAVmed is a medical device company.
Gained 10% to … for the treatment of Prader-Willi Syndrome.
6. Progenics Pharmaceuticals Inc. ( …
-
6 Top Gainers In Healthcare Sector (BIOC, AGEN, LPCN...)
18 Jan 2019 01:34 GMT
… in the pharma/biotech sector.
1. Biocept Inc … , formerly known as Kynapid, in the U.S … non-alcoholic steatohepatitis.
Treatment with LPCN 1144 showed … stage pharmaceutical companies namely, Rafael Pharmaceuticals Inc. and Lipomedix Pharmaceuticals Ltd …